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This was a cross-sectional study aimed to determine the prevalence of and to identify risk
factors for Chlamydia trachomatis (CT) among human immunodeﬁciency virus (HIV)-infected
women attending the acquired immunodeﬁciency syndrome (AIDS) clinic in the city ofMan-
aus, Brazil, in 2009-2010. Participants answered a questionnaire containing demographic,
epidemiological, and clinical data. A genital specimen was collected during examination
to detect CT-DNA by hybrid capture, and blood samples were taken to determine CD4+T
and HIV viral load. There were 329 women included in the study. Median age was 32
years (IQR=27-38) and median schooling was nine years (IQR=4-11). The prevalence of
CT was 4.3% (95%CI: 2.1-6.5). Logistic regression analysis showed that age between 18-29
years [OR=4.1(95%CI: 1.2-13.4)] and complaint of pelvic pain [OR=3.7 (95%CI: 1.2-12.8)] were
independently associated with CT. The use of condom was inversely associated with CT[OR=0.39 (95%CI: 0.1-0.9)]. The results showed that younger women who did not use con-
doms are at a higher risk for CT. Screening for sexually transmitted infections must be done
routinely and safe sexual practices should be promoted among this population.
ulation. Screening of CT in pregnant women in Brazil showed
7,8
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hlamydia trachomatis (CT) infection in the genitourinary tract
s the most prevalent bacterial sexually transmitted disease
1STD) worldwide. Genital chlamydial infection has a huge
mpact on sexual and reproductive health, and it is very com-
on in developed and developing countries.2–4 In developed
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CT is the most commonly diagnosed bacterial sexually trans-
mitted infection (STI) among adolescents and young adults.5,6
In Brazil, a highprevalence ofCT is observed in the female pop-s, Rua Pedro Teixeira, 25, Dom Pedro, Manaus, Amazonas,
a prevalence of nearly 10%.
In general, STIs increase the risk of HIV transmission and
are associated with more severe and earlier symptoms in
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Table 1 – Demographic and behavioral characteristics of
the 329 participating HIV-infected women, attendees of
the service of specialized care for AIDS in Manaus,
Amazonas, Brazil.
Variables CT positive CT negative p-value
n (%) n (%)
Age (years)
18 to 29 9 (64.3) 106 (33.7) 0.049
30 to 39 3 (21.4) 147 (46.7)
40 or more 2 (14.3) 62 (19.7)
Years of schooling
≤ 4 2 (14.3) 84 (26.7) 0.771
5 to 8 4 (28.6) 73 (23.2)
9 or more 8 (57.1) 158 (50.2)
Age ﬁrst sexually active
≤ 15 years 6 (42.9) 150 (47.6) 0.727
>15 years 8 (57.1) 165 (95.4)
Partner change in past 12 months
1 12 (85.7) 275 (87.3) 0.696
>1 2 (14.3) 40 (12.7)
History of STI
Yes 5 (35.7) 95 (30.2) 0.658
No 9 (64.3) 220 (69.8)
Sexual worker
Yes 2 (14.3) 50 (15.9) 0.874
No 12 (85.7) 265 (84.1)
Condom use
Yes 8 (57.1) 225 (71.4) 0.081
No 6 (42.9) 90 (28.6)
Illicit drug use336 braz j infect d
human immunodeﬁciency virus (HIV) infected patients. The
control of these infections represents a unique opportunity to
improve reproductive health of women living with HIV.9 Both
ulcerative and non-ulcerative STIs increased the risk of HIV
transmission by three to ten times, depending on the type and
etiology of the STD.9 HIV-infected individuals affected by an
STI have increased viral load in genital secretions,10,11 thereby
increasing considerably their potential of infectiousness and
transmission.
Some studies showed that the prevalence of CT amongHIV-
infected women ranges from 2% to 10%.12–15 In Brazil, a study
conducted in Rio de Janeiro found a prevalence of 3% for CT
among HIV-infected women.13 The aim of the current study
was to determine the prevalence of and risk factors associ-
ated with CT among HIV-infected women attending a referral
center for the care of AIDS patients.
Material and methods
This is a cross-sectional study conducted among HIV-infected
women who attended the service for specialized care for
AIDS at the Fundac¸ão de Medicina Tropical Dr. Heitor Vieira
Dourado (FMT-DHVD), Manaus city, state of Amazonas, Brazil,
from June 2009 to June 2010. HIV-infected women aged 18
to 49 years, not pregnant, and with no history of hysterec-
tomy were invited to participate in the study after signing an
informed consent. The Ethical Committee for Research of the
FMT-DHVD approved all of the procedures used in the study,
which was ﬁled under the Registration No. 327-09, 06/04/2009.
HIV-infected women diagnosed with CT during the study were
provided treatment in accordancewith theManual of STI Con-
trol Program of the Ministry of Health of Brazil.
An individual interview for all of the participants of the
study was conducted to complete a standardized question-
naire containing sociodemographical, epidemiological, and
clinical data. Each participant also underwent a clinical and
gynecological examination for genital specimen collection for
bacterioscopy, cytology, and the detection of CTDNAby hybrid
capture (QIAGENGroupCorporation). A 5mLblood samplewas
also collected for the determination of HIV viral load and CD4+
T-cell counts.
The sample size calculation was based on an average fre-
quency of CT of 5% (95% CI, =2%-8%).12–15 The required
number of participants was 292. Considering a loss of 20%,
the ﬁnal sample size was estimated as 350.
A descriptive analysis was performed for the sociode-
mographic, sexual history, and behavioral covariates. The
frequency distribution for qualitative variables and the
median and interquartile range (IQR) for quantitative vari-
ables were calculated. The prevalence of CT was estimated
along with the corresponding 95% conﬁdence interval (CI).
The chi-square test with Yates’ correction was used to assess
possible associations between demographic variables and
CT positivity. Fisher’s exact test was applied when appro-
priate. Multivariate logistic regression analysis was applied
to examine the independent effect of each demographic or
risk variable for CT diagnosis. All variables that were mod-
erately associated (p≤ 0.10) were considered for inclusion in
the multivariate model. In the ﬁnal analysis, variables with aYes 5 (35.7) 45 (14.3) 0.029
No 9 (64.3) 270 (85.7)
non-signiﬁcant association (p>0.05) were removed from the
model.
Results
A total of 329 (94%) HIV-infected women participated in the
study. The median age was 32 years with an interquartile
range (IQR) of 27 to 38. The median of years of schooling was
nine years (IQR=4-11). The overall prevalence of CT was 4.3%
(95% CI; 2.1%-6.5%).
The sociodemographic and behavioral characteristics of
the women in the current study are shown in Table 1. HIV-
infected women with positive hybrid capture for CT were
younger (18–29 years) than those with a negative test (64.3 vs.
33.7%, p=0.049). The use of illicit drugs was also more com-
mon inCT-infected thannon-infectedwomen (35.7% vs. 14.3%,
p=0.029).
The median CD4+T cell count and viral load were 338.5
(IQR=211.5 - 513.3) cells/mm3 and 497.5 (IQR=49-11,288)
copies/mm3 respectively. The clinical data of the partici-
pants are described in Table 2. A total of 261 HIV-infected
women (79.3%) were classiﬁed as AIDS patients. The report
of pelvic pain was more prevalent among CT-infected than
non-infected women (78.6% vs. 50.5%, p=0.040).
The ﬁnal multivariate logistic regression model showed
that age (18 to 29) [OR=4.1 (1.2 to 13.4)] and report of pelvic
braz j infect d i s . 201
Table 2 – Clinical characteristics of the 329 participating
HIV-infected women, attendees of the service of
specialized care for AIDS in Manaus, Amazonas, Brazil.
Variables CT positive CT negative p-value
n (%) n (%)
Pelvic pain
Yes 11 (78.6) 159 (50.5) 0.040
No 3 (21.4) 156 (49.5)
Vaginal discharge
Yes 10 (71.4) 172 (54.6) 0.215
No 4 (28.6) 143 (45.4)
Genital bleeding
Yes 1 (7.1) 32 (10.2) 0.956
No 13 (92.9) 283 (89.8)
Burning micturition
Yes 4 (28.6) 72 (22.9) 0.620
No 10 (71.4) 243 (77.1)
Recent use of antibiotics
Yes 2 (14,3) 68 (21.6) 0.742
No 12 (85,7) 247 (78.4)
CD4 T cell count (cells/mm3)
≤ 200 2 (14.3) 68 (21.6) 0.724
201 to 349 5 (35.7) 94 (29.8)
350 to 500 3 (21.4) 69 (21.9)
> 500 4 (28.6) 84 (26.7)
Viral load (copies/mL)
≤ 1000 6 (42.9) 176 (55.9) 0.098
>1000 8 (57.1) 139 (44.1)
Infection status
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5. CDC - Centers for Diseases Control and Prevention. ChlamydiaHIV 12 (85.7) 249 (79.0) 0.547
AIDS 2 (14.3) 66 (21.0)
ain [OR=3.7 (1.2 to 12.8)] were independently associated with
T positivity. Condom use was inversely associated with CT
OR=0.39 (0.1-0.9)].
iscussion
he prevalence of CT among HIV-infected women in the cur-
ent study was 4.3%. This is in line with reports from Rio
e Janeiro (Brazil) and Mombasa (Kenya) where a prevalence
f CT of 3% and 3.2%, respectively, was observed among
IV-infected women.3,16 However, this prevalence is lower
han that found among pregnant and parturient women in
razil,7,8 and that observed (9.7%) among HIV-infected women
n Thailand.15
An association of CT with younger age (18-29 years),
ith pelvic pain, and with unprotected sex (no condom use)
as observed. Similar ﬁndings have been reported in other
tudies.6–8,17–19 Young women are the most heavily affected
y CT. Early onset of sexual activity, having more than one
artner, and practice of unprotected sex further intensify the
isk of CT.20
Although cross-sectional studies are not ideal for deter-
ining risk factors, their application is justiﬁed for assessingheprevalence of and the associated factors for CT amongHIV-
nfected women, especially at their age of highest fecundity.
t is of utmost importance to demonstrate the vulnerability of2;16(4):335–338 337
this group of women to the complications of this infection in
women’s health. In this study, the possibility of response bias
cannot be ruled out. There is always a general tendency to
give socially acceptable answers. Moreover, the sensitivity of
the hybrid capture test for CT is lower than the test based on
nucleic acid ampliﬁcation. This may lead to an underestima-
tion of the prevalence. Conversely, the prevalence observed
in the current study may be higher as HIV women seeking
care at the clinics are potentially at higher risk for sexually
transmitted infections.
Chlamydial infection is often asymptomatic. If CT is not
detected by screening, it is unlikely to be reported. Due to
the lack of speciﬁc symptoms, CT diagnosis is rarely con-
sidered. Approximately 70% to 80% of individuals with CT
remain asymptomatic and undiagnosed.21 This renders the
control of the spread of CT difﬁcult as most of the asymp-
tomatic patients are unaware of their status and do not seek
treatment. The limited availability of laboratory tests for diag-
nosis of CT in Brazil further complicates the matter. CT can
cause genitourinary infections, pelvic inﬂammatory disease,
chronic pelvic pain, tubal-factor infertility, ectopic pregnancy
and cervical cancer.19,22 Infection during pregnancy and child-
birth can trigger preterm labor, ruptured membranes, and
low birth weight.23,24 Infants born from mothers with CT can
be infected during delivery through the birth canal and may
present conjunctivitis and pneumonia.25 In patients with HIV,
the co-infection with CT may prolong/or increase their poten-
tial of infectiousness, facilitating the transmission of HIV,
and this epidemiological synergy may be responsible for the
increased transmission of HIV in some populations.26
It is well known that when interventions in health services
are effectively implemented, the quality of care is improved
and consequently the condition of sexual and reproductive
health, thereby avoiding complications and having positive
effect in the control of the spread of STIs.27,28 The service of
specialized care for HIV women must be aware of the need for
STI screening in this vulnerable and high risk population.
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